RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Manhattan Scientifics Stock

Manhattan Scientifics Net Income 2025

Manhattan Scientifics Net Income

-1.17 M USD

Ticker

MHTX

ISIN

US5631221000

WKN

911936

In 2025, Manhattan Scientifics's profit amounted to -1.17 M USD, a -57.33% increase from the -2.73 M USD profit recorded in the previous year.

The Manhattan Scientifics Net Income history

YEARNET INCOME (M USD)
2023-1.17
2022-2.73
2021-3.64
20204.31
2019-1.22
2018-8.33
20171.55
2016-6.11
20158.01
2014-3.81
2013-1.93
2012-2.09
2011-2.29
2010-0.04
2009-0.45
2008-2.14
2007-3.01
2006-1.69
2005-0.22
2004-1.52

Manhattan Scientifics Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Manhattan Scientifics, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Manhattan Scientifics from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Manhattan Scientifics’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Manhattan Scientifics. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Manhattan Scientifics’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Manhattan Scientifics’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Manhattan Scientifics’s growth potential.

Manhattan Scientifics Revenue, EBIT and net profit per share

DateManhattan Scientifics RevenueManhattan Scientifics EBITManhattan Scientifics Net Income
20230 undefined-703,000 undefined-1.17 M undefined
202250,000 undefined-680,000 undefined-2.73 M undefined
202150,000 undefined-690,000 undefined-3.64 M undefined
202050,000 undefined-680,000 undefined4.31 M undefined
2019100,000 undefined-1.03 M undefined-1.22 M undefined
20180 undefined-1.44 M undefined-8.33 M undefined
2017140,000 undefined-2.28 M undefined1.55 M undefined
2016150,000 undefined-6.38 M undefined-6.11 M undefined
201560,000 undefined-6.25 M undefined8.01 M undefined
2014640,000 undefined-3.48 M undefined-3.81 M undefined
2013650,000 undefined-1.81 M undefined-1.93 M undefined
2012690,000 undefined-1.65 M undefined-2.09 M undefined
2011690,000 undefined-2.17 M undefined-2.29 M undefined
20101.69 M undefined10,000 undefined-40,000 undefined
2009630,000 undefined-400,000 undefined-450,000 undefined
20080 undefined-2.15 M undefined-2.14 M undefined
20070 undefined-3.44 M undefined-3.01 M undefined
20060 undefined-1.94 M undefined-1.69 M undefined
20050 undefined-1.62 M undefined-220,000 undefined
2004150,000 undefined-2.13 M undefined-1.52 M undefined

Manhattan Scientifics stock margins

The Manhattan Scientifics margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Manhattan Scientifics. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Manhattan Scientifics.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Manhattan Scientifics's sales revenue. A higher gross margin percentage indicates that the Manhattan Scientifics retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Manhattan Scientifics's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Manhattan Scientifics's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Manhattan Scientifics's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Manhattan Scientifics. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Manhattan Scientifics's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Manhattan Scientifics Margin History

Manhattan Scientifics Gross marginManhattan Scientifics Profit marginManhattan Scientifics EBIT marginManhattan Scientifics Profit margin
2023100 %0 %0 %
2022100 %-1,360 %-5,460 %
2021100 %-1,380 %-7,280 %
2020100 %-1,360 %8,620 %
2019100 %-1,030 %-1,220 %
2018100 %0 %0 %
2017-35.71 %-1,628.57 %1,107.14 %
2016100 %-4,253.33 %-4,073.33 %
2015100 %-10,416.67 %13,350 %
2014100 %-543.75 %-595.31 %
2013100 %-278.46 %-296.92 %
2012100 %-239.13 %-302.9 %
201184.06 %-314.49 %-331.88 %
201092.31 %0.59 %-2.37 %
2009100 %-63.49 %-71.43 %
2008100 %0 %0 %
2007100 %0 %0 %
2006100 %0 %0 %
2005100 %0 %0 %
2004100 %-1,420 %-1,013.33 %

Manhattan Scientifics Aktienanalyse

What does Manhattan Scientifics do?

Manhattan Scientifics Inc is an innovative company that operates in the world of science and technology. The company was founded in 1994 by Marvin Maslow and is based in New York City. It primarily focuses on developing advanced technologies in the fields of materials science, biotechnology, and medical technology. The business model of Manhattan Scientifics Inc is based on the discovery and development of new technologies, which are then licensed or sold. The company specializes in technology development and works closely with scientific institutions and researchers around the world. In the past, the company has collaborated closely with NASA and the Los Alamos National Laboratory, and has been able to bring several successful products to market. The various divisions of Manhattan Scientifics Inc include nanotechnology, biotechnology, and medical technology. In the field of nanotechnology, the company has developed advanced technologies for the production of ultralight, highly strong materials. These materials are used in aerospace, construction, and other industries where lightweight and durable materials are needed. The biotechnology division of Manhattan Scientifics Inc focuses on the development of novel therapies for cancer and other diseases. The company has successfully developed a new cancer therapy based on magnetic nanoparticles. These nanoparticles are introduced into the body and attach to cancer cells. They are then attracted and killed by an external magnetic field. Medical technology is another important division of Manhattan Scientifics Inc. The company has developed advanced technologies for the production of medical devices that provide more precise surgeries and treatments. One of Manhattan Scientifics Inc's successful innovations is a device that can precisely target tumors with high-energy radiation to destroy them. Manhattan Scientifics Inc has brought several successful products to market in the past. One example of such a product is the Greenshift Corporation System, which helps reduce emissions from airplanes. The company has also had successful collaborations with NASA on various projects, including the development of super-lightweight carbon fiber components. Overall, Manhattan Scientifics Inc is an innovative company that specializes in the development of new technologies. The company has successfully worked in various fields, including nanotechnology, biotechnology, and medical technology. Its business model is based on the discovery and development of new technologies, which are then licensed or sold. Through its collaborations with scientific institutions and researchers around the world, the company has developed and brought several successful products to market. Manhattan Scientifics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Manhattan Scientifics's Profit Margins

The profit margins of Manhattan Scientifics represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Manhattan Scientifics's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Manhattan Scientifics's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Manhattan Scientifics's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Manhattan Scientifics’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Manhattan Scientifics stock

How much profit has Manhattan Scientifics made this year?

Manhattan Scientifics has made -1.17 M USD this year.

How has the profit developed compared to last year?

The profit has increased by -57.33% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Manhattan Scientifics publish its earnings?

Manhattan Scientifics publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Manhattan Scientifics?

The profits of Manhattan Scientifics are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Manhattan Scientifics?

You can learn more about the earnings of Manhattan Scientifics by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Manhattan Scientifics pay?

Over the past 12 months, Manhattan Scientifics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Manhattan Scientifics is expected to pay a dividend of 0 USD.

What is the dividend yield of Manhattan Scientifics?

The current dividend yield of Manhattan Scientifics is .

When does Manhattan Scientifics pay dividends?

Manhattan Scientifics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Manhattan Scientifics?

Manhattan Scientifics paid dividends every year for the past 0 years.

What is the dividend of Manhattan Scientifics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Manhattan Scientifics located?

Manhattan Scientifics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Manhattan Scientifics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Manhattan Scientifics from 10/6/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/6/2025.

When did Manhattan Scientifics pay the last dividend?

The last dividend was paid out on 10/6/2025.

What was the dividend of Manhattan Scientifics in the year 2024?

In the year 2024, Manhattan Scientifics distributed 0 USD as dividends.

In which currency does Manhattan Scientifics pay out the dividend?

The dividends of Manhattan Scientifics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Manhattan Scientifics

Our stock analysis for Manhattan Scientifics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Manhattan Scientifics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.